| .
       
        
          |  Yu HUANG, Ph.D. (Cantab.), MAE, FISHR, FIUPS, FBPhS Jeanie Hu Professor of  Biomedical Sciences Chair Professor of Biomedical  Sciences and Vascular Biology
 Head, Department of  Biomedical Sciences (29 September 2021-)
 City University of Hong Kong, Hong Kong, China
 黃聿 博士(劍橋大學)  胡梁子慧生物醫學教授生物醫學及血管生物學講座教授, 香港城市大學生物醫學系主任
 Foreign Member, The  Academia Europaea (Academy of Europe) 歐洲科學院外籍院士
 https://www.ae-info.org/ae/Member/Huang_Yu
 Inaugural Research Grants Council  - Senior Research Fellow香港研究資助局首屆高級研究學者, 2021
 https://awards.ugc.edu.hk/awardees/yu-huang-2020
 Croucher Senior Research Fellow裘槎基金會裘槎優秀科研者獎,  2014
 https://croucher.org.hk/senior-research-fellow-yu-huang
 Fellow, International Union of Physiological  Sciences Academy of Physiology國際生理科學聯合會生理學院會士
 https://www.iups.org/physiology/iups-academy-of-physiology/
 Fellow, International Society for Heart Research國際心臟研究學會會士
 https://ishrworld.org/page/Fellows
 Fellow, British Pharmacological Society英國藥理學會會士
 https://www.bps.ac.uk/news/articles/2023/2023-fellows-and-honorary-fellows
 Associate Editor, Circulation Research, American  Heart Association美國心臟協會《循環研究》副主編
 https://www.ahajournals.org/res/editors
 1/F, To Yuen Building, 31 To Yuen St, Kowloon,  Hong KongTel: 852 34427746; Fax: 852 34420549
 Email: yu.huang@cityu.edu.hk
 Website: http://www.cityu.edu.hk/bms/profile/yuhuang.htm
 ORCID:  0000-0002-1277-6784ResearcherID: K-2866-2017
 Scopus ID: 57020209200
 Google Scholar: Yu HUANG
   ______________________________________________________________ Emeritus Professor,  School of Biomedical SciencesChinese University of  Hong Kong (28 Sept 2021 -)
 
 Adjunct Professor, School of Life Sciences, CUHK (28 Sept 2021 -)
 
 Professor of Biomedical Sciences (1 August 2010 – 27 Sept 2021)
 School of Biomedical Sciences, CUHK
 Member for the Council  of The Chinese University of Hong Kong (2015-2021)香港中文大學校董會成員(校董, 2015-2021)
 
 Fellow of The United  College Assembly, CUHK (2003-2022)
 香港中文大學聯合書院院務委員(2003-2022)
 Senior  College Tutor, The United College, CUHK (2022-)香港中文大學聯合書院資深書院導師 (2022-)
               Director (Basic Sciences), Heart and Vascular Institute, CUHK (2007 – 2021)香港中文大學心腦血管醫學研究所所長(2007-2021)
 Professor (by courtesy),  School of Life Sciences, CUHK (2009-2021)Professor (by courtesy), The Hong Kong Institute of Diabetes and Obesity, CUHK  (2014-2021)
 
 E-mail: yu-huang@cuhk.edu.hk
   |  |  
          | Qualifications |  
          | 
            
              Shanghai First Medical   College, CHINA  (Fudan University Shanghai   Medical College  since 2002), Degree  awarded (1983): Bachelor of Science
              Department  of Pharmacology, University of    Cambridge, UK,  Degree awarded (1985): Master of Philosophy
              Department of  Pharmacology, University of Cambridge,   UK, Degree  awarded (1988): Doctor of Philosophy
              American Heart  Association Post-doctoral Research Fellow Vermont-affiliated, 1988-1991), Department  of Pharmacology, University of Vermont,   USA
              Post-doctoral Research  Physiologist (1991-1993), Department of Physiology, University  of California, Los Angeles, USA |  
          | Recent External Competitive Grants as Principal  Investigator or Coordinator |  
          | 
            Hong  Kong Research Grants Council - General Research Fund (2025-2026) “Investigation of the role of TGFβ2 in the  development of atherosclerosis”. HK$ 1,208,830, No. 11103825             
              Hong Kong Research Grants Council -  General Research Fund (2024-2025) “Endothelial TFEB activation inhibits hypoxia-induced  pulmonary hypertension”. HK$ 1,559,580, No. 11103424 
              Hong Kong Research Grants Council – Theme-based Research Scheme  2023-2024 (Thirteenth Round) “Single-Cell Multi-Omics Study of  Atherosclerotic Vascular Disease:  Narrowing the Gap Between Bench and  Bedside”,  HK$  55,510,000, No. T12-101/23-N  
              
                Hong Kong Research Grants Council - General  Research Fund (GRF, 2023-2024) “Critical roles of endothelial FOXO1  activation in endothelial dysfunction during hypertension development”, HK$  1,600,000, No. 11101123Hong Kong Research Grants Council - General Research Fund  (GRF, 2023-2026) “Inflammasome  mediates YAP-induced chronic inflammation in endothelium during the initiation  of atherosclerosis”, HK$ 1,374,355, No.  11103222  
              Health       and Medical Research Fund [PI;       2022-2025) “Gut microbiota       remodelling contributes to the aging-induced endothelial dysfunction and       vascular oxidative stress” HK$1,500,000, Ref. 08190776 
              RGC -       General Research Fund [PI;       2022-2025]: "TGF-β2 ameliorates       pulmonary arterial hypertension" HK$1,513,122, No. 14100121. 
              
                Hong  Kong Research Grants Council – Senior Research Fellow Scheme (GRF, 2021-2025), HK$7,798,380  (No. SRFS2021-4S04)              Hong  Kong Research Grants Council - General Research Fund (GRF, 2021-2024): “Endothelial cell  Nrf2activation inhibits atherosclerosis”. HK$1,394,799,  No. 14109720             
              Health and Medical Research  Fund, Hong Kong Government (2020-2023) “Selective PPARα activation directly  protects vascular function through inhibition of YAP/TAZ-mediated oxidative  stress and inflammation” HK$1,500,000, No. 07181286              
              Natural Science Foundation of China, Major Research Program on Vascular  Homeostasis and Remodeling (國家自然科學基金重大研究計畫項目, Jan 2020 – Dec 2021): “Hemodynamic  regulation of atherogenesis: a  mechanistic and intervention study on the basis of systems biology”  RMB 2,400,000; No. 91939302             
              Hong  Kong Research Grants Council - General Research Fund (GRF, 2020-2023): “Scavenging mitochondrial ROS by UCP2  attenuates atherosclerosis through suppression of endoplasmic reticulum  stress”. HK$1,517,507, No. 14112919 
                            Health and Medical Research Fund, Hong Kong Government  (2019-2022) “Artificial sweeteners  improve vascular function and reduce oxidative stress in diabetes and obesity”  HK$1,500,000, No. 06173956             
              Hong Kong Research Grants  Council - General Research Fund (GRF, 2019-2022): “Suppression of Hippo pathway mediates endothelial  dysfunction through activating the BMP4-SMAD axis in metabolic disorder”. HK$868,956, No. 14109618             
              
                Health and Medical  Research Fund, Hong Kong Government (2018-2020): “Involvement of the Hippo pathway as a novel mechanism underlying the  beneficial effect of metformin against diabetic vasculopathy and insulin resistance. HK$1,200,000, No. 05161746
                Hong Kong Research  Grants Council – General Research Fund (GRF, 2018-2021): “Targeting YAP/TAZ activation to ameliorates  endothelial dysfunction in diabetic mice” HK$1,126,512, CUHK 14164817)
                Health  and Medical Research Fund, Hong Kong SAR Government (HMRF, 2017-2019): “Novel lipid-lowering-independent  benefits of statins against vascular dysfunction in metabolic syndrome” 1,199,176  HK$, No.04153276            
                Hong  Kong Research Grants Council – Collaborative Research Fund (CRF, 2017-2020): “A  multi-disciplinary study on the beneficial effects of PPARD in physical  exercise against diabetic vascular complications: cellular crosstalk and energy  metabolism” HK$6,817,834,C4024-16W        
                Hong Kong Research  Grants Council – General Research Fund (GRF, 2017-2019): “Targeting TFEB to reverse endothelial dysfunction in diabetic mice  through inhibition of autophagy” HK$1,317,102, CUHK 14124216)            
                Health and  Medical Research Fund, Hong Kong SAR Government (HMRF, 2016-2018): “Molecular mechanisms of red wine resveratrol  against metabolic vascular dysfunction” 1,199,696 HK$, No.13140871            
                Natural Science Foundation of China (NSFC) – National Health and Medical  Science Council, Australia (NHMRC) Joint Research Scheme (2016-2020 “Identifying the epigenomic fingerprint of coronary  heart disease in Chinese adults with type 2 diabetes” 3,500,000 RMB, No. 81561128017.            
                Health and Medical  Research Fund, Hong Kong SAR Government (HMRF, 2015-2017): “Cellular mechanisms underlying the  benefits of Danshen-derived salvianolic acid B against vascular inflammation  and dysfunction in diabetes” HK$999,916, No.  12134081            
                Hong Kong Research Grants Council - General Research Fund (GRF, 2014-2017):“Critical  role  of  Smad  signaling  in  mediating  vascular  inflammation  anddysfunction in diabetes and obesity” HK$959,868, CUHK14105814            
                Natural Science  Foundation of China (NSFC, 2013-2016): “Cross-talk  of the Toll-like receptor and bone morphogenic protein signaling and its function  in metabolic vascular dysfunction” RMB 1,600,000; No. 91339117.            
                Health and Medical Research Fund, Hong Kong SAR Government (HMRF, 2013-2015): “Investigation of In Vivo and In Vitro Vascular Benefits of Vitamin D in Mouse Model of Obesity and Diabetes”' HK$993,920, No. 01122226.            
                Hong Kong Research Grants Council – Collaborative  Research Fund (CRF, 2012-2015): “Physical exercise promotes vascular health: impact of  mechano-transduction and novel endothelium-derived regulators” HK$7,700,000, CUHK2/CRF/12G            
                Hong Kong Research Grants Council – General  Research Fund (GRF, 2012-2015): “Functional importance of PPARd and SIRT1  interaction in protecting endothelial function in diabetes and obesity” HK$1,300,000, CUHK464712            
                Hong Kong Research Grants Council – General  Research Fund (GRF, 2011-2014): “Endoplasmic  reticulum stress mediates endothelial dysfunction in diabetes and obesity” HK$1,000,000, CUHK465611            
                Hong Kong Research Grants Council – General  Research Fund (GRF, 2010-2013): “Novel  roles of uncoupling protein-2 against endothelial dysfunction and delayed  endothelial regenerative repair in diabetes” HK$1,247,290, CUHK466110            
                National Science Foundation of China/Hong Kong  Research Grants Council Joint Research Scheme (2009-2011): “PPARd activation prevents endothelial dysfunction in diabetes:  cellular mechanisms and clinical implications” HK$534,750, N_CUHK428/09            
                Health grant related studies related to melamine incident, Hong Kong SAR Food and Health Bureau (2009-2011): “Impact of  chronic tolerable daily intake of melamine and related compounds on renal and  vascular function in pregnant and neonatal rats” HK$ 809,194, MI-BS-12            
                Hong Kong Research Grants  Council – General Research Fund (GRF, 2008-2011): “Pivotal role of bone  morphogenic protein-4 in endothelial dysfunction in diabetes” HK$1,198,369, CUHK465308 |  
          | Research  Interests |  
          | 
            
              Endothelial and Metabolic Dysfunction, and Novel       Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency            
              Endothelium-derived Contracting Factors in the       Regulation of Vascular Tone            
              Adipose Tissue Regulation of Vascular Function in       Obesity, Diabetes and Hypertension                          Ischemic Stroke and Neuronal Damage 
              Pharmacological Characterization of New Anti-diabetic  and Anti-hypertensive Drugs. Hypotensive and antioxidant Actions of  Biologically Active Components of Traditional Chinese Herbs and Natural Plants  including Polypehnols and Ginsenosides  |  
          | Academic Profile |  
          |   
              Foreign  Member, Academia Europaea/Academy of Europe (Basic and Clinical Translational  Sciences Section) (April 2025)  Fellowships 
              Elected Fellow, British Pharmacological Society (October 2023)             
              Elected Fellow, Academy of Physiology, International Union of  Physiological Sciences (April 2023)             
              Elected Fellow of the International Society of Heart Research (ishr, 2019)             
              Inaugural  Hong Kong Research Grants Council (RGC)  Senior Research Fellow Award (2020 - 2021年度首屆香港研究資助局高級研究學者獎) 
              Croucher Senior  Research Fellowship Award (2014), Hong Kong Croucher Foundation (裘槎優秀科研者獎, 2014, 香港裘槎基金會) Major Awards and Honors 
              First-class  Award, The Natural Science Award, Hubei Province (中國湖北省2017年度科學技術獎 - 自然科學獎一等獎, September  2024)             
              2024 Peter Harris  Distinguished Scientist Award of the International Society for Heart Research (April  2024)             
              Outstanding Contribution  Award, Chinese Society for Vascular Medicine, Chinese Association of  Pathophysiology (病理生理學會血管醫學專業委員會傑出貢獻獎), 3 July 2021             
              2020 Wuxi  PharmaTech Life Science and Chemistry Award – The Scholar Award (2020年度藥明康德生命化學研究獎學者獎)             
              2019  Higher Education Outstanding Scientific Research Output Award (first-class  award), Ministry of Education, People Republic of China (國家教育部2019年度高等學校科學研究优秀成果獎 - 自然科學一等獎)  
              2017 Higher  Education Outstanding Scientific Research Output Award (second-class award),  Ministry of Education, People Republic of China (國家教育部2017年度高等學校科學研究优秀成果獎 - 自然科學二等獎,2018)             
              Research  Excellence Award 2016-2017, Chinese University of Hong Kong (香港中文大學研究卓越獎, 2017)             
              Second-class  Award, The State Natural Science Award, China (中國國家自然科學獎二等獎,2015)             
              First-class Award,  The Natural Science Award, Chongqing Municipality Government (中國重慶市科學技術獎 - 自然科學獎一等獎) (April 2013)             
              Research  Excellence Award 2011-2012, Chinese University of Hong Kong (香港中文大學研究卓越獎, 2012)             
              2011 Higher  Education Outstanding Scientific Research Output Award (second-class award),  Ministry of Education, People Republic of China (2011年度高等學校科學研究优秀成果獎 - 自然科學二等獎,2012)             
              The Postgraduate  Research Output Award 2011, Chinese University of Hong Kong (Mentor of the  awardee, Xiaoyu Tian)             
              The  Postgraduate Research Output Award 2009, Chinese University of Hong Kong  (Mentor of the awardee, Siu Ling Wong)             
              UM Macao Distinguished Visiting Scholar, University of Macau (2019)             
              Visiting  Professorship under Academic Icon Program, University of Malaya (2012-2016) Service to Major Scientific  Organizations 
              The International  Council Member, International Society of Heart Research (2025-)             
              Honorary President  of The Asian Society for Vascular Biology (2025-2027)             
              Scientific  Committee Member, State Key Laboratory of Cardiovascular Disease (中國醫學科學院阜外醫院)(心血管疾病全國重點實驗室第一屆學術委員會委員,March 2025 -)             
              Vice-President, Chinese Association for Physiological Sciences (中國生理學會副理事長, 5 Nov 2022)  
              Vice-President,  The Chinese Section, International Society of Heart Research (國際心臟研究會中國分會副主席,  2016-)             
              
                Vice Chairman  of the Academic Committee for The Key Laboratory of Geriatric Cardiovascular and Cerebrovascular Disease Research, Ministry of Education of China (老年心腦血管病教育部重點實驗室學術委員會副主任,  January 2024), 
              Vice Chairman of Academic Committee for Institute of Endocrine and  Metabolic Disease, University of Science and Technology of China and  Anhui Provincial Key Laboratory of Metabolic  Health and Panvascular Diseases (中國科學技術大學內分泌与代謝病研究所, 代謝建康与渙血管病安徽省重點實驗室學術委員會副主任 (August 2023)             
              Vice-President,  Society of Vascular Medicine, Chinese Association of Pathophysiology (中國病理生理學會心血醫學專業委員會副主任委員, 2015-2021)             
              President, Asian  Society for Vascular Biology (2010-2018)             
              Secretary-General  and the founding member of the Asian Society for Vascular Biology (2005-2010)             
              Council Member,  the Asian Society for Vascular Biology (2018-)             
              Elected voting  member (representing Asia) of the five-member Membership Committee, the  International Union of Basic and Clinical Pharmacology (IUPHAR) (2006-2018) 
              Member of the Scientific Committee,  State Key Laboratory of Cardiovascular Disease (心血管疾病國家重點實驗室學術委員會委員, April 2022 - March 2025)             
              Member of the Committee of  Experts on National Center for Cardiovascular Diseases (中國國家心血管專家委員會第二屆委員會委, Sept 2019 - Sept 2024 )             
              Elected Executive  Council Member of the Chinese Association for Physiological Sciences (Nov 2022-)             
              Council Member,  The Chinese Association of Pathophysiology (中國病理生理學會理事,2010-)             
              Elected Council  Member, The Chinese Society of Cardiovascular Pathophysiology (中國病理生理學會心血管專業委員會理事, 2008 -)             
              Council Member, Society  of Vascular Medicine, Chinese Association of Pathophysiology (中國病理生理學會心血醫學專業委員會理事, 2015-)             
              Council Member of the  Chinese Section, the International Society of Heart Research (國際心臟研究會中國分會理事, 2008-)             
              Council Member of  The International Society for Heart Research – Chinese Committee of  Translational Medicine (ISHR-CCTM) (2014-2016)             
              Executive Council  Member of The International Society for Heart Research – Chinese Committee of  Translational Medicine (ISHR-CCTM) (國際心臟研究會中國轉化醫學工作委員會常務理事, 2016-)             
              Executive Council  Member, The Chinese Society of Cardiovascular Pharmacology (中國藥理學會心血管專業委員會常務理事, 2007-)             
              Council Member,  The Chinese Society of Circulatory Physiology, Chinese Association for  Physiological Sciences (中國生理學會循?生理專業委員會理事2015 - 2018)             
              Executive Council  Member, Cardiovascular Immunology Sub-Committee, Chinese Society for Immunology  (中國免疫學會心血管免疫分會常務理事, June 2024-2028)             
              Executive Council  Member, 2nd Board of Specialty Committee of TCM Pharmacology, World  Federation of Chinese Medicine Societies (世界中醫藥學會聯合會中藥藥理專業委員會常務理事Jan 2014 - 2018)             
              Member of Public  Affair Committee, The Academy of Cardiovascular Research Excellence, USA (2003 -)             
              第三屆海峽兩岸醫藥衛生交流協會心血管專業委員會常務委員 (2021  – 2024) 
              Executive Council  Member (2000 - 2001) and Treasurer (2001 - 2008), Hong Kong Society of  Neurosciences             
              Executive Committee Member  (2003-), Honorary Secretary (2006 - 2008), and Treasurer (2009-2012), Hong Kong  Pharmacology Society             
              Hong Kong  Representative for Cardiovascular Conference across the Strait (2008 -)             
              Vice-President,  Hong Kong Society of Cell Biology (2018 -)  
              Council Member,  Institute of Cardiovascular Science and Medicine, Hong Kong (2008 -)             
              Vice-President,  Institute of Cardiovascular Science and Medicine, Hong Kong (2023-) 
              Founding Director  (Basic Sciences) of the Institute of Vascular Medicine at Chinese University of  Hong Kong (2007 - 2021)             
              Assistant Dean  (Research), Faculty of Medicine, Chinese University of Hong Kong (2006 - July  2013)             
              Secretary  (Internal Affair, 2011-2013), Vice-President (External Affair, 2013-2015,  2015-2017, 2017-2020), Council Member (2021-2023) for The Society of Hong Kong  Scholars  Major Lectures             
              Keynote  Lecture at 3rd Scientific Meeting of the Academy of Cardiovascular  Research Excellency Canada and 9th Canada-China symposium in  Atherosclerosis, Thrombosis and Vascular Biology, Winnipeg, Manitoba, Canada,  7-9 July 2025             
              Keynote Lecture at the 8th Asia-Pacific  CardioMetabolic Syndrome Congress (APCMS), Seoul, Korea, 23-24 May 2025 
              
                The Paul M Vanhoutte Memorial Lecture at the 9th Scientific  Meeting of the Asian Society for Vascular Biology, Nanjing, China, 30 November  2024Keynote Lecture at  the 7th Asia-Pacific CardioMetabolic Syndrome Congress (APCMS),  Seoul, Korea, 26 April 2024  
              2024 Peter Harris  Distinguished Scientist Award Lecture, ISHR Chinese Section Scientific Meeting,  Wuxi, China, 12 April 2024             
              Keynote Lecture at 8th International  Conference on Biomedical Engineering and Applications (ICBEA 2024), Tokyo,  Japan, 19 March 2024  
              Bei Shi Zhang Lecture (貝時璋講座) in University of Science and  Technology of China 18 August 2023             
              Keynote Lecture at  2023 Scientific Conference of Malaysian Society of Pharmacology and Physiology,  Malaysia, 7 August 2023  
              Keynote Lecture at 19th  World Congress of Basic and Clinical Pharmacology – WCP2023, Glasgow, Scotland, (04 July 2023)             
              The President’s  Lecture, City University of Hong Kong, 2 November 2022             
              The 9th  Asian Lecture on Vascular Biology at 8th Scientific Meeting of Asian  Society for Vascular Biology, Shanghai, China, 3 November 2018             
              The Robert F.  Furchgott Lecture at the MOVD 2013 (11th International Symposium on  Mechanisms of Vasodilatation), Zurich, Switzerland (4th October  2013)             
              The Office of Life  Sciences Distinguished Lecture at National University of Singapore (26 April  2007)  Service to Major Funding Agencies             
              Member  of Biology Panel for Research Assessment Exercise 2026, The University Grants  Committee (UGC) of Hong Kong (2024) 
              Member of the Biology and Medicine Panel of the  Research Grants Council, Hong Kong (December 2017 - 2023)               
                Member  of the Grant Review Board, Health and Medical Research Fund, Food and Health  Bureau, Hong Kong SAR Government (2013-)               
                Member  of Innovation and Technology Fund (ITF), Hong Kong Government’s Innovation and  Technology Commission (2023-) 
              Member of Review Panel of Major Research Program on  Regulation of Vascular Homeostasis and Remodeling”, Natural Science Foundation  of China (2014-)             
              Panel Member of University of Macau Multi-Year  Research Grant in Engineering and Science, University of Macau (2013-2020)             
              Chair of the Panel on Biomedical Sciences, the  Multi-Year Research Grant, University of  Macau (2021-)             
              Member of the Academic Committee of the Hong Kong Scholar Program, Hong  Kong Special Administrative Region (香江學者計劃, 2011 -)   Visiting and  Adjunct Professorships  
              Lecture Professorship,  Fudan University Shanghai Medical College (2005 – 2008; 2008 – 2011,  2011-); Adjunct Professorship, Xi’an Jiaotong University Medical  Centre (2005 - 2009); Lecture Professorship, Center of Medical Sciences, Guangdong Provincial People’s Hospital (2006); Guest  Professorship, Shanghai Jiaotong University Medical College (2007); Member of Scientific Committee, Shanghai  City Vascular Biology Key Laboratory (2007); Member of Academic Committee,  Shanghai City Key Laboratory of Hypertension (2014); Guest Professor, Jinan  University (2008); Guest Professorship, Peking University, School of Basic Medical  Sciences (2010); Guest  Professorship, Third Military Medical University (2010-); Distinguished Professorship,  Beijing Institute of Heart, Lung and Blood Vessel Diseases (2017); Member of Academic Committee, Center for Obesity  and Metabolic Disease at Peking University, China (2010); Member of Academic  Committee of Advanced Institute of Medical Sciences, Dalian Medical University  (2015); University of Science and Technology of China (2023)   External Assessor / Panel Member of Talent Programs 
              External Assessor of  The Chang Jiang Scholars Program, The Ministry of Education and Li Ka Shing  Foundation, China (教育部長江學者講座教授, 特聘教授,成就獎評審專家)             
              中國國家科技獎勵評審專家(2015年度國家自然科學獎會評專家,生物學組)             
              國家自然科學基金委員會醫學科學部科學國家杰出青年基金             
              國家自然科學基金委員會醫學科學部科學國家優秀青年基金  Review Service and Lectures 
              Regular  reviewer of manuscripts for 260 international journals and of abstracts for 14 international conferences             
              Regular  reviewer of grant proposals for 37 granting agencies and schemes of 15 countries and regions             
              504 invited  lectures and seminars at international, regional and local  conferences on vascular research Service to SCI-indexed Scientific Journals 
              Associate Editor, Experimental Physiology (London, 2002 -  2003)             
              Editor, Experimental Physiology (London, 2003 - 2006)             
              Editor (Vascular), Clinical and Experimental Pharmacology and  Physiology (Australia, 2007 - 2012)             
              Editor, Drug Discoveries &  Therapeutics (Japan, 2008 -)             
              Editor, Naunyn-Schmiedeberg's Archives of Pharmacology (Europe, 2012 - 2019)             
              Reviewer Editor, Frontiers in Pharmacotherapy of  Inflammation (Switzerland, 2010-), Frontiers  in Cardiovascular and Smooth Muscle Pharmacology (Switzerland, 2010-); Frontier in Vascular Physiology (Switzerland, 2010-); Frontiers in Ethnopharmacology (Switzerland, 2013 -)  
              Academic Editor, PLoS One (2011-2019, USA)             
              Associate Editor (Cardiovascular), Clinical  and Experimental Pharmacology and Physiology (2014 -  2018)             
              Co-Guest Editor for Journal of Cardiovascular Pharmacology (USA, 2014-2015)             
              Co-Guest Editor for British Journal of Pharmacology (UK,  2016-2017)             
              Editor for British Journal of Pharmacology (UK,  2018 -)             
              Associate Editor, Circulation Research (American Heart  Association, USA, 2019-) 
              Co-Guest Editor for Journal of Molecular and Cellular Cardiology (USA, 2021-2022)             
              Co-Guest Editor  for Antioxidants (2021-2022) 
              Member of  Editorial Advisory Board (past and present) for SCI-indexed journals Journal of Vascular Research, Europe (2007 - 2018); Cardiovascular Drug & Therapy,  Europe (2011-); The Journal of Pharmacy  and Pharmacology (UK, 2011-); Arteriosclerosis, Thrombosis and  Vascular Biology (USA,  2012-); Acta Pharmacologica Sinica (China, 2012-); Journal of Cardiovascular  Diseases & Diagnosis (USA, 2013-); Clinical  and Experimental Research in Cardiology (USA, 2014-); Scientific Reports (UK, 2014-2019); Biomedical Research (2016-); British Journal of  Pharmacology (UK, 2018-); Cardiovascular  Research (Europe, 2018-); Journal of Molecular and Cellular Cardiology (USA, 2018-) Chairman,  Organizing or Scientific Committee of international and regional conferences  
               Satellite Symposium to the World Congress of the International Society  for Heart Research (Hong Kong, 2004), International  Symposium on Mechanisms of Vasodilatation (Belgium, 2005), 11th International Symposium on Vascular Neuroeffector  Mechanisms – the Official Satellite  Symposium of the 15th World Congress of Pharmacology (main organizer, China, 2006), Scientific Meetings of Asian Society for  Vascular Biology  (China, 2005 & 2006, Singapore 2008, Hong Kong China 2010, Xi’an China 2012, Hualien Taiwan, China 2016,  Shanghai, China 2018), and Satellite Symposium to the  World Congress of the International Society for the Heart Research and to the International Society of Hypertension (China, 2006); International Symposium on Basic  Cardiology at The South China International Congress of Cardiology (China,  2006-), 9th and 10th International Symposium on  Resistance Arteries (ISRA, Hamilton Island, Australia, 2008; Denmark 2011); 10th International Symposium on Mechanism of Vasodilatation  (MOVD 2009, Sendai, Japan 2009); The 12th International Symposium on “Vascular Neuroeffector  Mechanisms” (Odense, Denmark, 24-26 June 2010); Paul M  Vanhoutte Research Symposium (November 2010); Endothelium-derived  Hyperpolarizing Factor (EDHF) 2012 (Paris, France,  2012); 11th International  Symposium on Mechanism of Vasodilatation (MOVD 2013, Zurich, Switzerland 2013); Joint Scientific Meetings of Asian Society for  Vascular Biology and  the 12th International Symposium on “Vascular Neuroeffector  Mechanisms” (Kuala Lumpur Malaysia, 2014); The Symposium on “Natural Product: Neuro-Metabolic-Vascular  Mechanisms” at 17th World Congress of Basic and Clinical  Pharmacology  (Cape Town, South Africa, 2014); 12th  International Symposium on Mechanism of Vasodilatation (MOVD 2016, Mayo Clinic, Rochester, MN, USA 2016); Canada-China  Symposium – ATVB 2016, Calgary, Canada 2016); 2019 World Congress of International Society for Heart Research  (Beijing, China, 2019);  13th International  Symposium on Mechanism of Vasodilatation and 7th International  Symposium on Endothelium-Dependent Hyperpolarization (Rotterdam,  The Netherlands, 2019); and  8th International Symposium on Endothelium-Dependent  Hyperpolarization (Hong Kong SAR, China,  2021); 22nd International Vascular Biology Meeting (IVBM, Oakland,  CA, USA, 2022); 2022 World Congress  of International Society for Heart Research, Berlin, Germany, 2022), 15th International Symposium on  Mechanism of Vasodilatation and 9th International Symposium on  Endothelium-Dependent Hyperpolarization (Oxford, United Kingdom, 2024);                       |  
         . |